• No results found

University of Groningen Advancing systems medicine based methods to predict drug response in diabetic kidney disease Mulder, Skander

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Advancing systems medicine based methods to predict drug response in diabetic kidney disease Mulder, Skander"

Copied!
33
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Advancing systems medicine based methods to predict drug response in diabetic kidney

disease

Mulder, Skander

DOI:

10.33612/diss.143946661

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date:

2020

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Mulder, S. (2020). Advancing systems medicine based methods to predict drug response in diabetic kidney

disease. University of Groningen. https://doi.org/10.33612/diss.143946661

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
(20)
(21)
(22)
(23)
(24)
(25)
(26)
(27)
(28)
(29)
(30)
(31)
(32)
(33)

Referenties

GERELATEERDE DOCUMENTEN

Advancing systems medicine based methods to predict drug response in diabetic kidney disease..

Advancing systems medicine based methods to predict drug response in diabetic kidney disease..

The long-term kidney protective effects of the sodium glucose co transporter 2 inhibitor dapaglifozin can be attributed in part to improvements in (renal) mitochondrial function.

Better prediction of drug response in diabetic kidney disease: a biomarker approach to personalize

[35–37] For the ARBs losartan and irbesartan as well as for the calcium antago- nist amlodipine, the PRE score predicted long-term renal and CV risk changes that were similar to

Volume overload is frequently observed in patients with type 2 dia- betes at high cardio-renal risk.[12,13] Extracellular volume restriction, by means of moderating dietary

Distribution of patients according to percentage change in proteinuria (UPCR ) and absolute change in total cholesterol (TC) from baseline to week 14; in all treatment groups (A)

We previously developed and validated a drug response score (multiple Parameter Response Efficacy [PRE] score) that translates the short-term drug effects on multiple